A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer
- 30 September 1999
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (9) , 1314-1319
- https://doi.org/10.1016/s0959-8049(99)00029-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The use of pharmacokinetics to improve the treatment of ovarian cancer: combination paclitaxel (TaxolR)-carboplatinInternational Journal of Gynecologic Cancer, 1997
- The use of the Calvert formula to determine the optimal carboplatin dosageZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- Prediction of Carboplatin Clearance From Standard Morphological and Biological Patient CharacteristicsJNCI Journal of the National Cancer Institute, 1995
- Further Refinement of Carboplatin DosingJNCI Journal of the National Cancer Institute, 1995
- Best Subsets Logistic RegressionBiometrics, 1989
- CarboplatinDrugs, 1989
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958